University of Minnesota Medical Center
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT01606852
Mechanical ventilation (MV) is the most frequently used life-support modality in intensive care units (ICUs). To reduce anxiety, stress and promote tolerance of MV, nurses frequently administer a variety of sedative medications to their patients based on subjective observations.
The investigators hypothesize that patient-controlled sedation, compared to clinician-directed sedation, will decrease sedative exposure while decreasing patient anxiety during the episode of mechanical ventilation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Minneapolis, Minnesota, 55455, United States
A study to determine whether critically ill patients, during a substantial portion of their time on mechanical ventilation, can reduce anxiety symptoms better with PCS than their caregivers while reducing over-sedation, duration of mechanical ventilation and length of ICU stay will require hundreds of subjects enrolled on a multi-day protocol. However, patient-controlled sedation has been used in less than 20 patients and only for less than 24 hours. Therefore this study is designed to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
loading dose (0.5 mcg/kg i.v.), followed by a continuous basal infusion (0.2-0.7 mcg/kg/hr) with 3 allowable patient-controlled self-boluses per hour (0.25 mcg/kg) each with a 20-minute lock-out. Study infusion up to 5 days.
Other names: Administered via a Lifecare PCA Infusion System (Hospira)
Time frame: 5 days after enrollment
Will use the sedation intensity score Scale is based on a score of 1 (full arousal) to 4 (no arousal)
Time frame: During 5 days of study protocol
arterial hypotension, bradycardia, self-extubations, and protocol violations related to drug, pump or both.
University of Minnesota
Other
Acronym: PCS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04468126
Acute Respiratory Failure, Hypoxemic Respiratory Failure
Poitiers, France
View Trial DetailsNCT04568642
Acute Hypoxemic Respiratory Failure, Acute Hypoxemic and Hypercapnic Respiratory Failure
Izmir, Turkey/izmir, Turkey (Türkiye)
View Trial DetailsNCT04965844
Acute Respiratory Failure, High Flow Nasal Cannula
Barcelona, Spain
View Trial DetailsNCT04655638
Acute Respiratory Failure, COVID-19
Larissa, Greece
View Trial Details